Kreutter v. Teladoc Health, Inc.

CourtDistrict Court, S.D. New York
DecidedSeptember 17, 2021
Docket1:19-cv-05875
StatusUnknown

This text of Kreutter v. Teladoc Health, Inc. (Kreutter v. Teladoc Health, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kreutter v. Teladoc Health, Inc., (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT ELECTRONICALLY FILED DOC #: _________________ SOUTHERN DISTRICT OF NEW YORK DATE FILED: 9/17/2021 -----------------------------------------------------------------X- MISTY PICKETT and CHANTELLE : KREUTTER, derivatively on behalf of TELADOC : HEALTH, INC. : : 1:19-cv-5875-GHW Plaintiffs, : : MEMORANDUM OPINION & -against- : ORDER : TELADOC HEALTH, INC. et al, : : Defendants. : : -------------------------------------------------------------------X - GREGORY H. WOODS, United States District Judge:

Plaintiffs Misty Pickett and Chantelle Kreutter brought this derivative action on behalf of Teladoc Health, Inc., against a number of the company’s directors and officers. On March 26, 2021, Magistrate Judge Barbara Moses issued a Report & Recommendation (the “R&R”) in response to the defendants’ motion to dismiss the complaint due to the plaintiffs’ failure to make a demand on the company prior to filing the action. Dkt. No. 82. Because the Court agrees with the recommendations made by Judge Moses in the R&R, the defendants’ motion to dismiss is GRANTED. I. BACKGROUND The R&R describes in detail the facts and procedural history of this case. The Court refers the reader to the R&R for a comprehensive description of the facts and procedural history of this case. A short review of the procedural history of the case is warranted, however. Ms. Kreutter initially filed this action on June 21, 2019, alleging derivative claims for violation of § 14 of the Exchange Act, breach of fiduciary duty and other alleged abuses. Dkt. No. 1. The Court referred the case to Judge Moses for general pre-trial management, as well for all dispositive motions on September 13, 2019. Dkt. No. 32. Judge Moses granted Ms. Kreutter leave to file an amended complaint on September 16, 2020. Dkt. No. 33. Ms. Kreutter filed her amended complaint on October 16, 2019. Dkt. No. 34. The defendants filed their first motion to dismiss in this case on December 13, 2019. Dkt. No. 39. In their motion, the defendants asserted that Ms. Kreutter had failed to make a proper pre- suit demand and that she had not adequately pleaded demand futility. Dkt. No. 40. While that motion was pending before the court, Ms. Pickett moved to intervene in the case. Dkt. No. 53. She

asked for a temporary “stay of consideration” of the pending motion to dismiss. In her brief, Ms. Pickett described that her own forthcoming complaint, unlike Ms. Kreutter’s, would be “informed by board-level books and records” obtained pursuant to 8 Del. Code § 220 (“§ 220”). Mem. in Supp. of Pickett. Mot., Dkt. No. 53-1, at 4, 19. Ms. Pickett and Ms. Kreutter eventually agreed to join forces—stipulating that they would jointly pursue a single action. Dkt. No. 69. They filed a joint amended complaint (the “JAC”) on June 4, 2020. Dkt. No. 72. It is the operative complaint in this case. The JAC again asserts derivative claims under § 14(a) of the Exchange Act, as well as for breach of fiduciary duty and other alleged abuses by officers and directors of the company. The JAC expressly incorporates by reference the documents obtained by Ms. Pickett under § 220. The defendants moved to dismiss the JAC, again as a result of the plaintiffs’ failure to make a pre-suit demand on the company and as a result of their failure to adequately plead demand futility.

Dkt. Nos. 73, 74. The motion was fully briefed. On March 26, 2021, Judge Moses issued her R&R recommending that the complaint be dismissed because the plaintiffs had failed to adequately allege demand futility. She also recommended that the plaintiffs not be granted leave to amend the complaint. Plaintiffs filed timely objections to the R&R (the “Objections”). Dkt. No. 85. The plaintiffs presented no objections to the principle recommendation of the R&R—namely, that the complaint be dismissed. They objected only to the recommendation that the Court deny the plaintiffs leave to amend. Id. The defendants filed a response (the “Response”) to the Objections. Dkt. No. 86. In the Response, the defendants argue that the R&R’s recommendation that leave to amend be denied is well-founded given that the plaintiffs have already presented three complaints in this case to the Court, and because the plaintiffs have not identified any factual issues that they would raise that would cure the evident deficiencies in the JAC.

II. LEGAL STANDARD A district court reviewing a magistrate judge’s report and recommendation “may accept, reject, or modify, in whole or in part, the findings or recommendations made by the magistrate judge.” 28 U.S.C. § 636(b)(1). Parties may raise specific, written objections to the report and recommendation within fourteen days of receiving a copy of the report. Id.; see also Fed. R. Civ. P. 72(b)(2). When a party timely objects to a magistrate’s report and recommendation, a district court reviews, de novo “those portions of the report or specified proposed findings or recommendations to which objection is made.” 28 U.S.C. § 636(b)(1)(C). But where “the party makes only frivolous, conclusory or general objections, or simply reiterates her original arguments, the Court reviews the report and recommendation only for clear error.” Chen v. New Trend Apparel, Inc., 8 F. Supp. 3d 406, 416 (S.D.N.Y. 2014) (quoting Silva v. Peninsula Hotel, 509 F. Supp. 2d 364, 366 (S.D.N.Y. 2007)).

“Further, the objections ‘must be specific and clearly aimed at particular findings in the magistrate judge’s proposal.’” McDonaugh v. Astrue, 672 F. Supp. 2d 542, 547 (S.D.N.Y. 2009) (quoting Molefe v. KLM Royal Dutch Airlines, 602 F. Supp. 2d 485, 487 (S.D.N.Y. 2009). The Court also reviews for clear error those parts of the report and recommendation to which no party has timely objected. 28 U.S.C. § 636(b)(1)(A); Lewis v. Zon, 573 F. Supp. 2d 804, 811 (S.D.N.Y. 2008). III. DISCUSSION The Court adopts Judge Moses’ recommendation that the JAC be dismissed. As described above, the plaintiffs did not object to any part of her analysis or conclusion with respect to that topic. As a result, the Court has reviewed those portions of the R&R for plain error and has found none. Accordingly, the defendants’ motion to dismiss is granted. The Court also adopts Judge Moses’ recommendation that the plaintiffs not be granted leave

to amend the JAC further. The Court has reviewed that recommendation de novo. At the outset, the Court acknowledges that in this circuit, “[i]t is the usual practice upon granting a motion to dismiss to allow leave to replead.” Cortec Indus., Inc. v. Sum Holding L.P., 949 F.2d 42, 48 (2d Cir. 1991); see also Fed. R. Civ. P. 15(a)(2) (“The court should freely give leave [to amend] when justice so requires.”). “Complaints dismissed under Rule 9(b) are almost always dismissed with leave to amend,” unless the plaintiff has had a prior opportunity to amend its complaint or the allegations were made after full discovery in a related case. Luce v. Edelstein, 802 F.2d 49, 56 (2d Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Silva v. Peninsula Hotel
509 F. Supp. 2d 364 (S.D. New York, 2007)
Molefe v. KLM Royal Dutch Airlines
602 F. Supp. 2d 485 (S.D. New York, 2009)
McDonaugh v. Astrue
672 F. Supp. 2d 542 (S.D. New York, 2009)
Lewis v. Zon
573 F. Supp. 2d 804 (S.D. New York, 2008)
F5 Capital v. Pappas
856 F.3d 61 (Second Circuit, 2017)
Chen v. New Trend Apparel, Inc.
8 F. Supp. 3d 406 (S.D. New York, 2014)
Luce v. Edelstein
802 F.2d 49 (Second Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Kreutter v. Teladoc Health, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kreutter-v-teladoc-health-inc-nysd-2021.